Home » AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough

This post was originally published on this site.

Sheer mass helps when enlarged balance sheets allow for bigger bets on potential blockbuster drugs